Injection
PT-141 (Bremelanotide)
Bremelanotide injection · same price with auto-refill
From $151/mo
For low sexual desire
PT-141 (bremelanotide) compounded by a licensed pharmacy, a licensed provider's review and free shipping in one plan. No office visit.
From $151/mo with the 12-month plan, same price with or without auto-refill

How would you like to pay?
Choose your plan
Prescription treatment requires an online medical evaluation. A provider decides whether treatment is appropriate; approval is not guaranteed.
Shop Bremelanotide Rx
Each product is reviewed by a licensed provider and shipped free from a licensed pharmacy.
Injection
Bremelanotide injection · same price with auto-refill
From $151/mo
Nasal spray
Tadalafil, oxytocin and PT-141 in one 10 mL spray
From $143/mo
Nasal spray
Oxytocin nasal spray, by prescription
From $183/mo
Your plan
A licensed provider reads your health intake and decides if PT-141 is right for you.
Bremelanotide for injection, prepared by a licensed compounding pharmacy after approval.
Delivered to your door at no added cost.
Pay once or turn on auto-refill. The price is the same either way.
Free tools to check the Vyleesi label limits, side-effect odds and study doses.
Help with your order and delivery when you need it.
How it works
Pick 1, 3, 6 or 12 months. The price is the same with or without auto-refill.
Answer a private online questionnaire. A licensed provider reviews it.
If prescribed, the pharmacy prepares your PT-141 and ships it to you free.
FAQ
The things people ask most before starting Bremelanotide.
$189 for 1 month, $510 for 3 months ($170 a month), $964 for 6 months ($160.67 a month) or $1,814 for 12 months ($151.17 a month). The price is the same with auto-refill or one-time. Shipping is included.
Yes. You complete an online health intake and a licensed provider decides whether PT-141 is right for you. Choosing a plan does not guarantee a prescription.
Bremelanotide is FDA approved only as Vyleesi, a 1.75 mg single-dose autoinjector. The PT-141 sold here is compounded by a licensed 503A pharmacy. It is not Vyleesi and is not FDA approved. FDA does not verify compounded drugs for safety, effectiveness or quality before they are sold.
PT-141 in this plan is an injection. Your provider sets your dose and schedule. On the Vyleesi label, the dose is 1.75 mg under the skin at least 45 minutes before sex, no more than once in 24 hours and no more than 8 times a month.
The Vyleesi label covers premenopausal women with acquired, generalized low sexual desire that causes distress. It does not cover men, women after menopause, or use to enhance sexual performance. Earlier work on erectile dysfunction in men did not lead to an approved product. Your provider decides if PT-141 fits you.
In the phase 3 trials, the most common were nausea (40% vs 1.3% on placebo), flushing (20.3% vs 0.3%) and headache (11.3% vs 1.9%). Nausea was most common after the first dose. Blood pressure also rises briefly after each dose.
The Vyleesi label says not to use it with uncontrolled high blood pressure or known heart disease. It can cause darker patches of skin, and it can slow how well some oral medicines, such as naltrexone, are absorbed. Tell your provider about every medicine you take.
There is no set timeline. The Vyleesi label says to stop after 8 weeks if there is no improvement in desire. Your provider reviews how it is going.
No. You can pay once for 1, 3, 6 or 12 months, or turn on auto-refill. The price is the same either way.